Tag results:
in silico
Prostate Cell News
Discovery of a New Candidate Drug to Overcome Cabazitaxel-Resistant Gene Signature in Castration-Resistant Prostate Cancer by In Silico Screening
[Prostate Cancer and Prostatic Diseases] Researchers used screening tests for candidate drugs targeting cabazitaxel (CBZ)-resistant-related gene expression and identified pimozide as a potential candidate for overcoming CBZ resistance in castration-resistant prostate cancer.
Intestinal Cell News
Oxysterol Binding Protein-Like 3 (OSBPL3) Is a Novel Driver Gene That Promotes Tumor Growth in Part through R-Ras/Akt Signaling in Gastric Cancer
[Scientific Reports] Gastric cancer (GC) is one of the most lethal malignant tumors. Researchers identified novel driver genes and clarified their roles in GC.
Extracellular Matrix News
Rutin Inhibited the Advanced Glycation End Products-Stimulated Inflammatory Response and Extracellular Matrix Degeneration via Targeting TRAF-6 and BCL-2 Proteins in Mouse Model of Osteoarthritis
[Aging] Scientists screened rutin (RT) for its activity against osteoarthritis with in vivo and in vitro models of osteoarthritis. Pretreatment of RT decreased the ECM degradation, inhibited expression of TRAF-6 and BCL-2 the NF-κB/MAPK pathway proteins.
Hematopoiesis News
Targeting the Actin Nucleation Promoting Factor WASp Provides a Therapeutic Approach for Hematopoietic Malignancies
[Nature Communications] Since Wiskott–Aldrich Syndrome protein (WASp) is exclusively expressed in hematopoietic cells, scientists performed in silico screening to identify small molecule compounds that bound WASp and promoted its degradation.
Cancer Stem Cell News
SNAI1-Mediated Transcriptional Regulation of Epithelial-to-Mesenchymal Transition Genes in Breast Cancer Stem Cells
[Cellular Signalling] Researchers performed in silico analysis of microarray data from luminal, Her2+, and triple-negative breast cancer cell lines and identified 15 relatively unexplored epithelial-to-mesenchymal (EMT)-related differentially expressed genes along with the markedly high expression of EMT-transcription factor, SNAI1.
Prostate Cell News
In Vitro and In Silico Studies of Holothurin a on Androgen Receptor in Prostate Cancer
[Journal of Biomolecular Structure and Dynamics] Scientists investigated the potential of using a marine triterpenoid saponin, holothurin A, on targeting androgen receptor expression of prostate cancer using in vitro and in silico studies.